• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟喹诺酮类药物对禁食和葡萄糖负荷小鼠血浆葡萄糖水平的影响。

Effect of fluoroquinolones on plasma glucose levels in fasted and glucose-loaded mice.

作者信息

Hori Seiji, Kizu Junko, Kawamura Masahiro

机构信息

Department of Pharmacology (I), Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan.

出版信息

J Infect Chemother. 2006 Apr;12(2):109-11. doi: 10.1007/s10156-006-0429-z.

DOI:10.1007/s10156-006-0429-z
PMID:16648952
Abstract

In fasted mice, plasma glucose levels were reduced by intraperitoneal administration of enoxacin, lomefloxacin, or gatifloxacin (50 mg/kg). A lower dose of these fluoroquinolones (5 mg/kg) also reduced the plasma glucose (PG) levels in glucose-loaded mice. Ciprofloxacin and levofloxacin did not reduce these levels in either fasted or glucose-loaded mice. These results suggest that each fluoroquinolone has an individual hypoglycemic action, and fluoroquinolone administration after meals might reduce PG levels at lower doses.

摘要

在禁食小鼠中,腹腔注射依诺沙星、洛美沙星或加替沙星(50毫克/千克)可降低血浆葡萄糖水平。较低剂量的这些氟喹诺酮类药物(5毫克/千克)也可降低葡萄糖负荷小鼠的血浆葡萄糖(PG)水平。环丙沙星和左氧氟沙星在禁食或葡萄糖负荷小鼠中均未降低这些水平。这些结果表明,每种氟喹诺酮类药物都有单独的降血糖作用,餐后服用氟喹诺酮类药物可能以较低剂量降低PG水平。

相似文献

1
Effect of fluoroquinolones on plasma glucose levels in fasted and glucose-loaded mice.氟喹诺酮类药物对禁食和葡萄糖负荷小鼠血浆葡萄糖水平的影响。
J Infect Chemother. 2006 Apr;12(2):109-11. doi: 10.1007/s10156-006-0429-z.
2
A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.对接受加替沙星、左氧氟沙星、环丙沙星或头孢曲松治疗的住院患者血糖异常情况进行回顾性比较评估。
Pharmacotherapy. 2005 Oct;25(10):1303-9. doi: 10.1592/phco.2005.25.10.1303.
3
Severe dysglycemia with the fluoroquinolones: a class effect?氟喹诺酮类药物所致的严重血糖异常:是类效应吗?
Clin Infect Dis. 2009 Aug 1;49(3):402-8. doi: 10.1086/600294.
4
In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.新型二氟喹诺酮洛美沙星对尿液细菌分离株的体外活性:与依诺沙星和氧氟沙星的比较。
J Chemother. 1989 Jul;1(4 Suppl):176-7.
5
Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patients.加替沙星和左氧氟沙星对老年住院患者低血糖和高血糖发生率的影响。
Pharmacotherapy. 2007 Nov;27(11):1498-505. doi: 10.1592/phco.27.11.1498.
6
In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.依诺沙星对环丙沙星、氟罗沙星、洛美沙星、氧氟沙星、培氟沙星和芦氟沙星的体外抗尿路病原体活性。
Chemotherapy. 1998 Mar-Apr;44(2):77-84. doi: 10.1159/000007096.
7
Overview of the fluoroquinolone antibiotics.氟喹诺酮类抗生素概述。
Pharmacotherapy. 1993 Mar-Apr;13(2 Pt 2):4S-17S.
8
Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study.加替沙星或左氧氟沙星治疗后住院患者的低血糖症:巢式病例对照研究。
Pharmacotherapy. 2005 Oct;25(10):1296-302. doi: 10.1592/phco.2005.25.10.1296.
9
Safety concerns with fluoroquinolones.氟喹诺酮类药物的安全性问题。
Ann Pharmacother. 2007 Nov;41(11):1859-66. doi: 10.1345/aph.1K347. Epub 2007 Oct 2.
10
Photocleavage of DNA by the fluoroquinolone antibacterials.氟喹诺酮类抗菌药物对DNA的光切割作用。
J Photochem Photobiol B. 1998 Aug 21;45(1):51-9. doi: 10.1016/S1011-1344(98)00160-2.

引用本文的文献

1
The Effects of Moxifloxacin and Gemifloxacin on the ECG Morphology in Healthy Volunteers: A Phase 1 Randomized Clinical Trial.莫西沙星和吉米沙星对健康志愿者心电图形态的影响:一项1期随机临床试验
Diagnostics (Basel). 2023 Mar 24;13(7):1234. doi: 10.3390/diagnostics13071234.
2
Enoxacin induces oxidative metabolism and mitigates obesity by regulating adipose tissue miRNA expression.恩诺沙星通过调节脂肪组织 miRNA 表达诱导氧化代谢并减轻肥胖。
Sci Adv. 2020 Dec 2;6(49). doi: 10.1126/sciadv.abc6250. Print 2020 Dec.
3
Enoxacin extends lifespan of C. elegans by inhibiting miR-34-5p and promoting mitohormesis.
恩诺沙星通过抑制 miR-34-5p 和促进线粒体应激延长秀丽隐杆线虫的寿命。
Redox Biol. 2018 Sep;18:84-92. doi: 10.1016/j.redox.2018.06.006. Epub 2018 Jun 19.
4
Establishing a murine model of the hematopoietic syndrome of the acute radiation syndrome.建立急性辐射综合征造血综合征的小鼠模型。
Health Phys. 2012 Oct;103(4):343-55. doi: 10.1097/HP.0b013e3182667309.
5
Safety profile of the fluoroquinolones: focus on levofloxacin.氟喹诺酮类药物的安全性概况:以左氧氟沙星为例。
Drug Saf. 2010 May 1;33(5):353-69. doi: 10.2165/11536360-000000000-00000.
6
Dysglycaemias and fluoroquinolones.血糖异常与氟喹诺酮类药物
Drug Saf. 2008;31(4):283-92. doi: 10.2165/00002018-200831040-00002.
7
An evaluation of the effects of gatifloxacin on glucose homeostasis.加替沙星对葡萄糖稳态影响的评估。
Pharm World Sci. 2008 Oct;30(5):544-9. doi: 10.1007/s11096-008-9205-8. Epub 2008 Feb 23.